EGFR and lung adenocarcinoma: Since gain-of-function EGFR mutations tend to be mutually exclusive with loss-of-function SPRED1 and NF1 mutations in lung adenocarcinoma (Collisson et al., 2014) (Figure S5A), we used oncogenic EGFR(L858R) as a model system.